- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 475/14 - Benz [g] pteridines, e.g. riboflavin
Patent holdings for IPC class C07D 475/14
Total number of patents in this class: 23
10-year publication summary
|
1
|
5
|
0
|
2
|
2
|
1
|
0
|
4
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Trioptotec GmbH | 16 |
7 |
| The Board of Trustees of the Leland Stanford Junior University | 6653 |
2 |
| ELC Management LLC | 1157 |
2 |
| ADS Therapeutics LLC | 56 |
2 |
| Lucid Psycheceuticals Inc. | 10 |
2 |
| Bontac Bio-Engineering (Shenzhen) Co., Ltd | 74 |
1 |
| Cambridge Enterprise Limited | 1246 |
1 |
| The Hospital for Sick Children | 411 |
1 |
| I-sens, Inc. | 432 |
1 |
| Sogang University Research & Business Development Foundation | 244 |
1 |
| Chelsea Technologies Group Ltd | 3 |
1 |
| Bontac Invitrolife Bio-technology (Shenzhen) Co., Ltd | 16 |
1 |
| Jiangxi Bonzymes Biotechnology Co., Ltd. | 8 |
1 |
| Other owners | 0 |